| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |